Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Virginia Cancer Specialists | Researchclopedia

Back to institutions

Virginia Cancer Specialists

Annandale, Virginiahealthcare

1,288

Works

47,563

Citations

94

h-index

Top Research Topics

Lung Cancer Treatments and Mutations Cancer Immunotherapy and Biomarkers HER2/EGFR in Cancer Research

Top Researchers

Gabriel N. Hortobágyi The University of Texas MD Anderson Cancer Center

1,905 works139,599 citationsh-index: 187

Recent Research

89O BMS-986504 with or without gemcitabine (GEM) + nab-paclitaxel (nab-P) in patients (pts) with pancreatic ductal adenocarcinoma (PDAC) and homozygous MTAP deletion (MTAP-del) from CA240-0007

B. George,Konstantinos Leventakos,et al.

20260 citations

Colorectal Cancer Treatments and Studies

Lung Cancer Research Studies

Cancer Genomics and Diagnostics

Monoclonal and Polyclonal Antibodies Research

Lymphoma Diagnosis and Treatment

Cancer Treatment and Pharmacology

Advanced Breast Cancer Therapies

CAR-T cell therapy research

Chronic Lymphocytic Leukemia Research

Jonathan E. Shaw University of Tasmania

868 works127,438 citationsh-index: 122

Lance A. Liotta George Mason University

1,053 works91,293 citationsh-index: 149

Michael Gnant Comprehensive Cancer Center Vienna

1,096 works77,885 citationsh-index: 102

Gϋnter von Minckwitz German Breast group

871 works61,487 citationsh-index: 110

Antonio C. Wolff Johns Hopkins University

900 works58,651 citationsh-index: 99

Setidegrasib in Advanced Non–Small-Cell Lung Cancer and Pancreatic Cancer

Wungki Park,Anup Kumar Kasi,et al.

20260 citations

112P Safety of valemetostat and pembrolizumab in advanced or metastatic 1L NSCLC without actionable genomic alterations expressing PD-L1 with TPS ≥ 50%: Interim results from the phase Ib trial

S. Gordon,M-J. Ahn,et al.

20260 citations

1O Efficacy and safety of setidegrasib in patients (pts) with advanced NSCLC with KRAS G12D mutation

L. Paz-Ares,A. Spira,et al.

20260 citations

Pan-tumor activity of olomorasib, a next-generation KRAS G12C inhibitor in KRAS G12C-mutant advanced solid tumors: a first-in-human study

Yonina R. Murciano-Goroff,Antoine Hollebecque,et al.

20260 citations

BET inhibitor OPN-2853 in advanced solid tumors and lymphoma: results from the phase 1b PLX124-01 trial

Michael S. Gordon,Richard D. Carvajal,et al.

20260 citations